Advanced Search

 

Study ID Status Title Patient Level Data
C93-015 Completed A Study to Investigate the Pharmacokinetics of Lamivudine (GR109714X) in Patients with Impaired Hepatic Function
C93-019 Completed A Study to Assess the Absolute Bioavailability of Fluticasone Propionate From a Dry Powder Formulation Using a Multidose Powder Inhaler
C93-020 Completed A study to assess the absolute bioavailability of Fluticasone propionate from dry powder formulation using the Diskhaler®
C93-060 Completed A study to investigate the safety, tolerability, pharmacodynamic and pharmacokinetic response to two doses of oral GR85548A separated by 4 hours.
C93-070 Completed A study to investigate the dose proportionality of oral tablet GR85548A pharmacokinetics in healthy female volunteers.
C93-077 Completed A study to investigate the relative bioavailability of ondansetron syrup and Zofran tablets 4 mg
C93-078 Completed A study to investigate the effect of oral sumatriptan on the intraocular pressure of healthy subjects.
C93-081 Completed A study to investigate the pharmacokinetics of oral GR85548 in subjects with impaired renal function.
C93-085 Completed A study to assess the pharmacokinetics of inhaled fluticasone propionate from a dry powder formulation using the Diskhaler® upon repeat dosing.
C93-087 Completed A study to investigate whether alcohol has an effect on the safety, tolerability, pharmacokinetics or pharmacodynamics of GR85548.
C93-097 Completed A study to determine the dose equivalence for systemic effects for salmeterol compared with salbutamol given by MDI in healthy subjects.
C94-016 Completed A study to investigate the effect of 6mg subcutaneous sumatriptan on oesophageal motility.
C94-027 Completed A Study to Assess the Absolute Bioavailability of Fluticasone Propionate after Oral Doses (0.1 mg, 1 mg, 10 mg)
C94-034 Completed A study to determine the absolute bioavailability of oral GR85548A.
C94-036 Completed An ascending dose, parallel group study to compare the effects of oral GR85548A on blood pressure in healthy subjects and in hypertensive patients taking anti-hypertensive therapy.
C94-042 Completed A Study to Assess the Absolute Bioavailability of a Single Dose of Inhaled Fluticasone Propionate Administered Via Nebulisation
C94-045 Completed A study to investigate the potential central function effect of GR85548.
C94-057 Completed A study to investigate the effects of the monoamine oxidase A inhibitor, moclobemide, on the pharmacokinetics, safety and tolerability of oral sumatriptan.
C94-071 Completed A study to investigate the safety, tolerability and pharmacokinetics of repeat dosing with oral GR85548A for 5 days.
C95-036 Completed A study to investigate the pharmacokinetics of oral naratriptan (GR85548A) in subjects with impaired hepatic function.
CAE10004 Completed A study to determine the bioequivalence of reformulated 125mg/5mL cefuroxime axetil oral suspension (CAOS) to standard marketed 125mg/5mL suspension at a dose of 250mg. Study Listed on ClinicalStudyDataRequest.com
CAE10005 Completed A study to determine the bioequivalence of reformulated 250mg/5mL cefuroxime axetil oral suspension (CAOS) to standard marketed 250mg/5mL suspension. Study Listed on ClinicalStudyDataRequest.com
CAE40408 Completed An open-label study of sequential therapy with intravenous cefuroxime followed by oral cefuroxime axetil for the treatment of community acquired pneumonia (CAP)
CAL.201 Completed A multicenter, randomized, double-blind study of the safety and efficacy of emulsion formulation calcipotriene foam 0.005% vs vehicle foam, dovonex; (calcipotriene) ointment 0.005% and vehicle ointment in the treatment of mild to moderate plaque-type psoriasis
CAL.203 Completed A randomized, open-label study to assess the bioavailability of emulsion formulation calcipotriene foam, 0.005%, and dovonex® ointment, 0.005%, in patients with mild to moderate plaque-type psoriasis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.